20 years ago, The Journal of Headache and Pain published its first article. After receiving its first Impact Factor in 2008, it has developed into one of the leading fully open access journals in its field.
To kick off our celebrations, please enjoy this letter written by the Editor in Chief, Paolo Martelletti, reflecting on the journal's inception and the contributions of scientists from around the world that have made the journal into what it is today.
Celebrating 20 years of The Journal of Headache and Pain
Aims and Scope - now also encouraging basic science submissions
The Journal of Headache and Pain is a peer-reviewed open access journal published under the brand BMC, part of Springer Nature. It is specifically dedicated to researchers involved in all aspects of headache and related pain syndromes, including epidemiology, public health, basic science, translational medicine, clinical trials and real-world data.
With a multidisciplinary perspective, The Journal of Headache and Pain covers headache medicine and related pain syndromes in all medical disciplines and particularly encourages clinical, translational and basic science submissions in the areas of pain management, genetics, neurology and internal medicine. The Journal publishes research articles, reviews, letters to the Editor as well as consensus articles and guidelines, which promote best practice in the management of patients with headaches and related pain.
Announcing the launch of In Review
The Journal of Headache and Pain, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:
- Share their work with fellow researchers to read, comment on, and cite even before publication
- Showcase their work to funders and others with a citable DOI while it is still under review
- Track their manuscript - including seeing when reviewers are invited, and when reports are received
Articles
-
-
Dural arteriovenous fistulas and headache features: an observational study
-
Prevalence and risk factors associated with headache amongst medical staff in South China
-
Microglia P2X4R-BDNF signalling contributes to central sensitization in a recurrent nitroglycerin-induced chronic migraine model
-
The epidemiology of headaches among patients with epilepsy: a systematic review and meta-analysis
-
Headache associated with cough: a review
-
The red ear syndrome
-
Safety and patients’ satisfaction of transcutaneous Supraorbital NeuroStimulation (tSNS) with the Cefaly® device in headache treatment: a survey of 2,313 headache sufferers in the general population
-
Blocking CGRP in migraine patients – a review of pros and cons
-
A common cause of sudden and thunderclap headaches: reversible cerebral vasoconstriction syndrome
Most mentioned in 2018
Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort
Baron EP., Lucas P. and Hogue O.
Migraine is first cause of disability in under 50s: will health politicians now take notice?
Steiner TJ., Stovner LJ., Vos T., Jensen R. and Katsarava Z.
Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study
Schwedt TJ, Alam A., Reed ML., Fanning KM., Munjal S. et al.
Medication-overuse headache: a widely recognized entity amidst ongoing debate
Vandenbussche N., Laterza D., Lisicki M., Lloyd J., Lupi C. et al.
The association between migraine and physical exercise
Amin FM., Aristeidou S., Baraldi C., Czapinska-Ciepiela EK., Ariadni DD. et al.
PACAP38 and PAC1 receptor blockade: a new target for headache?
Rubio-Beltrán E., Correnti E., Deen M., Kaam K., Kelderman T. et al.
Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?
Ashina M., and Martelletti P.
Altered muscle activity during rest and during mental or physical activity is not a trait symptom of migraine - a neck muscle EMG study
Leudtke K., Mehnert J. and May A.
My Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed
Martelletti P., Schwedt TJ., Lanteri-Minet M., Quintana R., Carboni V. et al.
Migraine and cluster headache – the common link
Vollesen AL., Benemei S., Cortese F., Labastida-Ramírez A., Marchese F. et al.
(Publication year 2018. Data collected February 2019. Source: Altmetric)
Top cited 2017-2018
Migraine is first cause of disability in under 50s: will health politicians now take notice?
Timothy J. Steiner, Lars J. Stovner, Theo Vos, R. Jensen and Z. Katsarava
Blocking CGRP in migraine patients - a review of pros and cons
Marie Deen, Edvige Correnti, Katharina Kamm, et al.
Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design
Daniel Serrano, Richard B. Lipton, Ann I. Scher, et al.
Calcitonin gene-related peptide and pain: a systematic review
Wendy Sophie Schou, Sait Ashina, Faisal Mohammad Amin, et al.
Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study
Andrew M. Blumenfeld, Richard J. Stark, Marshall C. Freeman, et al.
Interictal brain activity differs in migraine with and without aura: resting state fMRI study
Péter Faragó, Bernadett Tuka, Eszter Tóth, et al.
Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)
Simona Sacco, Gabriele S. Merki-Feld, Karen Lehrmann Ægidius, et al.
Altered functional connectivity of amygdala underlying the neuromechanism of migraine pathogenesis
Zhiye Chen, Xiaoyan Chen, Mengqi Liu, et al.
Mindfulness and pharmacological prophylaxis after withdrawal from medication overuse in patients with Chronic Migraine: an effectiveness trial with a one-year follow-up
Licia Grazzi, Emanuela Sansone, Alberto Raggi, et al.
The effect and safety of monoclonal antibodies to calcitonin gene-related peptide and its receptor on migraine: a systematic review and meta-analysis
Min Hou, Haiyan Xing, Yongqing Cai, et al.
(Publication years 2017-2018. Data collected December 2019. Source: Web of Science)
European Headache Federation School of Advanced Studies
The European Headache Federation School of Advanced Studies (EHF-SAS) aims to support headache science and offers young EU scientists high quality educational activities to enhance their critical spirit and skills to face headache medicine from a multidisciplinary perspective.
The EHF-SAS covers the richness and diversity of headache medicine fields, including basic science, clinical science, and diagnostic science, and places an emphasis on collaborative projects. The European Headache Federation will support its fellows’ activities allowing them to independently build their own plan sided by the EHF-SAS Scientific Committee.
Editorial Office
Editor in Chief (Founding)
Paolo Martelletti, MD,
Department of Clinical and Molecular Medicine
Sapienza University of Rome
Via di Grottarossa 1035
I-00189 Rome, Italy
Tel.: +39-06-33775111
Fax: +39-06-33775110
E-mail: paolo.martelletti@uniroma1.it
Assistant to the Editor: Valerio De Angelis
E-mail: valerio.deangelis@uniroma1.it
Thematic Series
Animal models in headache research
Edited by Dr Cenk Ayata and Dr Andrea M. Harriott
The changing face of migraine
Edited by Prof Messoud Ashina, Prof Lars Edvinsson and Prof Paolo Martelletti
Migraine Aura - Current understanding and future perspectives
Edited by Dr Anders Hougaard, Prof Paolo Martelletti and Dr Michele Viana
Hot topics in headache and pain from the EHF-SAS
Edited by Prof Paolo Martelletti
Latest blogs
-
-
How do sex hormones influence migraine?
02 September 2019
-
The New Era Of Disease Modifying Migraine Drugs (DMMDs)
01 September 2019
Editorial Board Spotlight
Prof. Alessandro Bozzao is Full Professor in Neuroradiology in the University of Rome, Sapienza (NESMOS Department). His research focused on diagnostic neuroradiology especially concerning cerebrovascular diseases, demyelinating diseases and brain neoplasms. Many of his studies evaluated Magnetic Resonance Imaging in the selection of stroke treatment and characterization of brain tumors.
Academic education in headache
The demand for a broad, complete and independent education in Headache Disorders has increased over time. The following international Masters courses guarantee a full coverage of this area of clinical medicine.
For more information:
Master in Headache Medicine - 17th Edition
Academic Year 2019-2020
https://web.uniroma1.it/masterheadache/
Master of Headache Disorders - 2nd Edition
Academic Years 2018-2020
http://mhd.ku.dk
Advertisement
Affiliated with
-
-
The Journal of Headache and Pain is affiliated with the European Headache Federation and Lifting the Burden.
Annual Journal Metrics
-
Speed
30 days to first decision for reviewed manuscripts only
23 days to first decision for all manuscripts
61 days from submission to acceptance
18 days from acceptance to publication
Citation Impact
3.918 - 2-year Impact Factor
4.195 - 5-year Impact Factor
1.138 - Source Normalized Impact per Paper (SNIP)
01.106 - SCImago Journal Rank (SJR)
Usage
725,406 Downloads
905 Altmetric mentions
- ISSN: 1129-2377 (electronic)
- ISSN: 1129-2369 (print)
Related reading
-
Societal Impact of Headache
-
Neuromodulation in Headache and Facial Pain Management
-
Cluster Headache and other Trigeminal Autonomic Cephalgias
-
Peripheral Interventional Management in Headache
-
Placebos and Nocebos in Headaches
-
Gender and Migraine
-
Headache and Comorbidities in Childhood and Adolescence
-
Comorbidities in Headache Disorders
-
Pharmacological Management of Headaches
-
Pathophysiology of Headaches
Advertisement
